Journal of Clinical & Molecular Pathology is a multidisciplinary peer-reviewed journal that publishes manuscripts on clinical pathology, anatomic pathology, and application of molecular biology, biochemistry, genetics, proteomics, chemistry, hematology and microbiology for the diagnosis of diseases. The journal focuses on the publication of manuscripts showcasing current concepts and techniques as well as novel findings in the field of clinical and molecular pathology.
The Journal of Clinical & Molecular Pathology emphasizes on the publication of current developments in the diagnostic methods and the adept detection of chronic diseases like cancer and infectious diseases based on the laboratory analysis. The journal serves the need of the medical practitioners, researchers, lab professionals, students, academicians and industry involved in the clinical pathology.
The Journal of Clinical & Molecular Pathology highlights the role of molecular changes in the organs and tissues of the body during the induction of diseases as a diagnostic tool. The journal encourages submissions on fields like molecular profiling of pathogens, analysis of pathogens, antimicrobial resistance, clinical pathology, chemical pathology, hematopathology, cytogenetics, molecular genetics pathology, clinical microbiology, immunopathology etc.
The journal widely publishes on clinical and molecular pathology practices as research articles, review articles, case reports, short communication, commentary, letters to editor and editorials. The journal ensures the highest standards in selection, review and rapid publication of manuscripts. All relevant papers are accepted for publication after a thorough review process. Once accepted, papers are published online and freely accessible.
Submission, reviewing and processing of the articles will be done through the Editorial Manager System for quality peer review process. The editorial manager system provides easy access to the authors to track the progress in the review process in an automated way.
Cell damage can occur as a result of an adverse stimulus which disrupts the normal homeostasis of affected cells. Among other causes, this can be due to physical, chemical, infectious, biological, nutritional or immunological factors. Cell damage can be reversible or irreversible. Depending on the extent of injury, the cellular response may be adaptive and where possible, homeostasis is restored. Cell death occurs when the severity of the injury exceeds the cell’s ability to repair itself. Cell death is relative to both the length of exposure to a harmful stimulus and the severity of the damage caused. Cell death may occur by necrosis or apoptosis.
Leukemia is a group of cancer cells that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. These white blood cells are not fully developed and are called blasts or leukemia cells. Bleeding and bruising problems are especially associated with leukemia. These symptoms occur due to a lack of normal blood cells.
Molecular pathology is an emerging discipline within cell biology and pathology conditions which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or body fluids. Molecular pathology relates some aspects of conditions with both anatomic pathology and clinical pathology, molecular biology, biochemistry, proteomics and genetics, and is sometimes considered a "crossover" discipline. It is multi-disciplinary in nature and focuses mainly on the sub-microscopic aspects of disease. A major consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues (traditional anatomic pathology) and on molecular testing.
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.
Cancer is a genetic disorder in which the normal control of cell growth is lost. Cancer genetics is now one of the fastest expanding medical specialties. At the molecular level, cancer is caused by mutation(s) in DNA, which result in aberrant cell proliferation. Most of these mutations are acquired and occur in somatic cells. However, some people inherit mutation(s) in the germline. The mutation occurs in two classes of cellular genes: oncogenes and tumour suppressor genes.
Cancer Research, Journal of the National Cancer Institute, Clinical Cancer Research, International Journal of Cancer, European Journal of Cancer, Molecular Cancer Therapeutics, Molecular Cancer Research, Cancer Chemotherapy and Pharmacology, Current Cancer Drug Targets
Anatomical pathology is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues.
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells.
Clinical chemistry (also known as chemical pathology, clinical biochemistry or medical biochemistry) is the area of clinical pathology that is generally concerned with analysis of bodily fluids for diagnostic and therapeutic purposes. All biochemical tests come under chemical pathology. These are performed on any kind of body fluid, but mostly on serum or plasma. Serum is the yellow watery part of blood that is left after blood has been allowed to clot and all blood cells have been removed.
Clinical Biochemistry, Clinical Chemistry, Annals of Clinical Biochemistry, Open Clinical Chemistry Journal, Japanese Journal of Clinical Chemistry, Comparative Clinical Pathology, Clinical Medicine Insights: Pathology
Dermatopathology is a joint subspecialty of dermatology and pathology and to a lesser extent of surgical pathology that focuses on the study of cutaneous diseases at a microscopic and molecular level. It also encompasses analyses of the potential causes of skin diseases at a basic level with clinical dermatologists.
Haematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. Haematology includes the study of pathology of blood cells. It involves treating diseases that affect the production of blood and its components, such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation.
Surgical pathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical pathology involves gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists.
Histopathology is the microscopic examination of biological tissues to observe the appearance of diseased cells and tissues in very fine detail. The main use of histopathology is in clinical medicine where it typically involves the examination of a biopsy (i.e. a surgically removed sample or specimen taken from a patient for the purposes of detailed study) by a specialist physician called a pathologist.
Biochemistry, sometimes called biological chemistry, is the study of chemical processes within and relating to living organisms. By controlling information flow through biochemical signalling and the flow of chemical energy through metabolism, biochemical processes give rise to the complexity of life. Over the last decades of the 20th century, biochemistry has become so successful at explaining living processes that now almost all areas of the life sciences from botany to medicine to genetics are engaged in biochemical research.
Journal of Biological Chemistry, Biochemistry, Analytical Biochemistry, International Journal of Biochemistry and Cell Biology, Journal of Cellular Biochemistry, Pharmacology, Biochemistry & Behavior, Journal of Biochemistry, Biochemistry and Cell Biology, Cell Biochemistry and Biophysics, Biotechnology and Applied Biochemistry, Cell Biochemistry and Function
An oncovirus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, often called oncornaviruses to denote their RNA virus origin. It now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus". The vast majority of human and animal viruses do not cause cancer, probably because of longstanding co-evolution between the virus and its host.
Journal of Clinical Oncology, Lancet Oncology, Annals of Oncology, Annals of Surgical Oncology, Radiotherapy and Oncology, Seminars in Oncology, Critical Reviews in Oncology/Hematology, Nature Reviews Clinical Oncology, Oncology, Neuro-Oncology, Oncology Reports, American Journal of Clinical Oncology, Molecular Oncology, Future Oncology
Proteomics is the large-scale study of proteins. Proteins are vital parts of living organisms, with many functions. The proteome is the entire set of proteins, produced or modified by an organism or system. This varies with time and distinct requirements, or stresses, that a cell or organism undergoes. Proteomics is an interdisciplinary domain that has benefited greatly from the genetic information of the Human Genome Project; it is also emerging scientific research and exploration of proteomes from the overall level of intracellular protein composition, structure, and its own unique activity patterns. It is an important component of functional genomics.
Molecular and Cellular Proteomics, Proteomics, Journal of Proteomics, Expert Review of Proteomics, Proteomics - Clinical Applications, Clinical Proteomics, Current Proteomics, Proteomics Insights, Human Genomics and Proteomics, Open Proteomics Journal, Proteomics Research Journal
*2016 Journal Impact Factor was established by dividing the number of articles published in 2014 and 2015 with the number of times they are cited in 2016 based on Google search and the Scholar Citation Index database. If 'X' is the total number of articles published in 2014 and 2015, and 'Y' is the number of times these articles were cited in indexed journals during 2016 then, impact factor = Y/X
Author(s): Ali Hilal-alnaqbi, Sawsan Dagher, Razan Alkhatib and Mohamed Al-Rubeai
Author(s): Richard A. Prayson, Elizabeth E. O Toole
Author(s): Novis D
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : April 29, 2017